Status:

COMPLETED

ATN 151 Work-to-Prevent: Employment as HIV Prevention

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute on Drug Abuse (NIDA)

Conditions:

HIV Prevention

Eligibility:

MALE

16-24 years

Phase:

NA

Brief Summary

The investigators aim to pilot-test a novel social and structural-level HIV intervention for YMSM and YTW of color ages 16-24.

Detailed Description

Work2Prevent will advance the science by adapting, tailoring, and pilot-testing a novel social and structural-level HIV intervention for YMSM and YTW of color ages16-24 aimed at increasing economic st...

Eligibility Criteria

Inclusion

  • Phase 2
  • Being male or assigned male at birth (YTW)
  • Identifies as a man who has sex with men (YMSM) and/or a gay bisexual man or transgender woman/transwoman
  • Identifies as African American/Black or Hispanic/Latino
  • 16-24 years old
  • English-speaking (primary)
  • Currently unemployed but seeking employment, or employed only part-time (35 hrs or less on avg/wk)
  • Is able to attend a 4-session employment program
  • Phase 2

Exclusion

  • Individuals identifying as non-Hispanic White
  • Individuals not assigned male at birth
  • Individuals with a known HIV positive-status at time of consent
  • Phase 3 Inclusion Criteria:
  • Being male or assigned male at birth (YTW)
  • Identifies as a man who has sex with men (YMSM) and/or a gay bisexual man or transgender woman/transwoman
  • Identifies as African American/Black or Hispanic/Latino
  • 16-24 years old
  • English-speaking (primary)
  • Currently unemployed but seeking employment, or employed only part-time (35 hrs or less on avg/wk)
  • Is able to attend a 4-session employment program
  • Did not participate in Phase 2
  • Phase 3

Key Trial Info

Start Date :

March 20 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 5 2019

Estimated Enrollment :

92 Patients enrolled

Trial Details

Trial ID

NCT03313310

Start Date

March 20 2018

End Date

December 5 2019

Last Update

November 24 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Chicago

Chicago, Illinois, United States, 60637